Email Updates

You are here

Home

16 JULY 2021 VOLUME 23 ISSUE 28

Media Coverage

  • UN Shift on HIV Prevention Raises Hope We Can End AIDS by 2030 – Now We Need To Turn Words Into Action

    The latest UN Declaration on AIDS does not speak more forcefully on the need to protect the human rights of key populations at risk for HIV, but there are significant shifts, including an unprecedented commitment to HIV combination prevention.

    July 16, 2021
    General
    Daily Maverick

  • Malawi: HIV and AIDS Fight Suffer Blow As UK Terminates Funding

    The Malawi Government has to brace for tougher times in the fight against HIV and AIDS following the decision by the United Kingdom (UK) to terminate assistance to Concern-led Consortium due to financial challenges.

    July 16, 2021
    General
    All Africa

  • COVID Is Especially Risky for People With HIV, Large Study Finds

    People living with HIV are more likely to become severely ill with COVID-19 and more likely to die if hospitalized than others infected with the coronavirus, according to a large new study. Nearly half of HIV-infected men older than 65 who are hospitalized for COVID-19 may die, the study found.

    July 15, 2021
    General
    New York Times

  • How Uganda Is Spearheading Efforts To Tackle Pediatric HIV

    Florence, aged 6, is one of almost 38 million people worldwide living with HIV, 1.7 million of whom are aged under 15 and usually contract HIV from their mothers during pregnancy, childbirth, or breastfeeding. Sub-Saharan Africa is home to nearly 90 percent of children living with HIV, while approximately 95,000 Ugandan children have the virus.

    July 15, 2021
    Treatment
    Devex

  • HIV Advocates Urge Feds to Invest in Social Needs, Curb Stigma

    Advocacy groups for people with HIV are calling for federal investment in affordable housing, food security, and other social programs as part of the US's broader fight against the epidemic.

    July 15, 2021
    Bloomberg Law

  • PrEP Use Disparities Worsening Between Early and Late Adopting States

    A recent study conducted by investigators from the Division of Infectious Diseases and International Health at the University of Virginia, in collaboration with the National Alliance of State and Territorial AIDS Directors, has found that disparities in preexposure prophylaxis (PrEP) use among individuals with PrEP indications worsened between early and late adopting states between 2014 and 2018.

    July 15, 2021
    PrEP
    Contagion Live

  • 100 Years of a Tuberculosis Vaccine With Limited Benefit

    On July 18, 1921, a newborn child in Paris became the first person to receive an experimental dose of the Bacille Calmette-Guérin vaccine for tuberculosis. A century later, it’s now the most commonly used vaccine in the world. It is also still the only licensed vaccine for the disease.

    July 15, 2021
    General
    Devex

  • Gilead Will Stop Giving Clinics Big Paybacks on PrEP Scripts—But a Bigger Issue Looms

    Beyond the Gilead reimbursement cutbacks, however, a larger issue is looming with PrEP access and adherence. Access remains higher among white gay men than among Black gay men—meanwhile, Black gay men and Black transgender women still have the highest HIV rates in the United States.

    July 15, 2021
    PrEP
    The Body

  • Opinion: Youths Have the Power To Address Asia’s Blind Spot

    Persistent stigmatization of sexual health in Asia is hindering access to testing and treatment across the region. This is helping fuel sexually transmitted infections among adolescents and young adults in a number of countries. If left unabated, it could ruin the decades of hard work that nations in the region have invested to eradicate the epidemic.

    July 14, 2021
    General
    Devex

  • #BREAKING: Dapivirine, Vaginal Ring Approved For Use In Zimbabwe

    The Vaginal Ring was submitted to the Medicines Control Authority of Zimbabwe (MCAZ) for review on March 5, 2021 and according to MCAZ procedures, approval for a medical drug or innovation usually takes between three months or a few years, depending on the completeness of the technical information that would have been submitted to the authority.

    July 14, 2021
    Microbicides
    Health Times

  • Advocates Aren’t Happy About Drug-Patent Language in the Updated UNAIDS Document That Sets the Global AIDS Agenda

    Every five years, reps from governments and advocacy groups around the world come together via the United Nations to haggle out a document, called a political declaration, that sets the global agenda on fighting AIDS for the half-decade to come. In 2016, for example, the document said that the world was aiming for fewer than 500,000 new HIV infections, fewer than 500,000 AIDS deaths, and no more HIV-related discrimination by 2020. As is often the case with these declarations, the goal was not met: In 2020 alone, about 1.5 million people seroconverted and nearly 700,000 died of AIDS.

    July 13, 2021
    General
    The Body

  • How to Needle Vladimir Putin on HIV Prevention

    Drug use is fueling Russia’s growing HIV caseload. To respond, the World Health Organization endorses so-called harm reduction programs, like distributing clean needles. However, the Russian government opposes harm reduction, preferring to take a harder line on drugs.

    July 13, 2021
    General
    POLITICO

  • The Latest on HIV Care, Cure, and PrEP

    The COVID-19 pandemic has overshadowed innovations in HIV care and prevention, says Tonia Poteat, PhD, MPH, PA-C, a primary HIV care and HIV preexposure prophylaxis (PrEP) clinician and associate professor of social medicine at the University of North Carolina, Chapel Hill. So even though the US Food and Drug Administration approved monthly injections of cabotegravir/rilpivirine (Cabenuva) in January, none of her patients are taking it.

    July 13, 2021
    PrEP, Treatment
    Medscape

  • Global Philanthropists Pledge £94M to Cover UK Foreign Aid Cuts

    A group of global philanthropists, including Bill Gates, have pledged £93.5m to help cover the shortfall left by the UK government’s cuts to foreign aid. After the government cut funding by about a third in the autumn spending review, many “critical” projects have stalled or been put at risk. The consortium, according to the Sunday Times, said they did not want to see drugs wasted because health projects had been forced to close down.

    July 11, 2021
    General
    The Guardian

  • HIV-Positive Man Shares Joy at Taking His Last HIV-Medication Pill

    An advocate for those living with HIV has shared his happiness at being able to stop having to take a daily pill to treat his HIV. Earlier this year, the FDA approved the first injectable treatment for the virus. Morris Singletary’s physician is switching him from daily pills to these monthly injections. This is a development that many of those living with HIV might not have imagined would ever come.

    July 10, 2021
    Treatment
    Queerty

  • Let’s Use the Lessons from COVID to End HIV

    Much has been written and will continue be written about the victories and failures of America’s battle with COVID-19.There’s already broad consensus that the pandemic taught our health care system a lot about fighting a highly contagious, deadly virus, and we hope this will make us better prepared for the next infectious disease threat.

    July 10, 2021
    Scientific American

  • HIV/AIDS and COVID: A Dual Battle

    In the shadow of this new pandemic, we have also seen some of the hard-won gains against HIV, TB, and malaria begin to unravel—especially in countries where COVID vaccination is scarce. The reality is, we cannot end AIDS or achieve other global health and development goals unless we beat COVID globally. However, it is also true that we cannot beat COVID without learning lessons from the global HIV response. As a third wave of COVID mounts in Africa, and the toll of the pandemic worsens in India and South America, we need action that is as strategic as it is bold.

    July 7, 2021
    General
    Think Global Health

Published Research

Announcements